Kelly Schoenbeck, MD
Assistant Professor
Medicine
School of Medicine

I am a junior researcher interested in studying the health-related quality of life of patients with hematologic malignancies

Awards

Show all (6) Hide

• Award Supplement, American Society of Hematology, 2021-2022
• Research Training Award for Fellows, Year 2, American Society of Hematology, 2021-2022
• Research Training Award for Fellows, American Society of Hematology, 2020-2021
• Rachel Pearline Award, UCSF Hematology & Oncology Fellowship Program, 2018
• Resident of the Month, Columbia University Internal Medicine Residency Program, 2014
• Gold Humanism Honor Society, Oregon Health and Science University (OHSU), 2011

Education & Training

Show all (4) Hide

• Hematology and Oncology Fellowship University of California San Francisco (UCSF) 2021
• Internal Medicine Residency New York Presbyterian - Columbia University Medical Center 2015
• M.D. School of Medicine Oregon Health and Science University (OHSU) 2012
• BA Psychology; Political Science Washington University in St. Louis 2005

Publications (11)

Top publication keywords:
Multiple MyelomaProtein Kinase InhibitorsImmunologic FactorsQuality of LifeRemission InductionPatient Reported Outcome MeasuresHematopoietic Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFrailtyParentingPhysiciansAccidental FallsBortezomibHematologic NeoplasmsNeoplasms, Plasma Cell

• Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.
  Journal of the National Cancer Institute 2022 Schoenbeck KL, Atallah E, Lin L, Weinfurt KP, Cortes J, Deininger MWN, Kota V, Larson RA, Mauro MJ, Oehler VG, Pinilla-Ibarz J, Radich JP, Schiffer CA, Shah NP, Silver RT, Thompson JE, Flynn KE
• Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice.
  Leukemia & lymphoma 2024 Pianko MJ, Mian HS, Schoenbeck KL, Wildes TM
• Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.
  Blood advances 2023 Tsang M, Bischoff K, Schoenbeck KL, Berry K, O'Riordan D, Fakhri B, Wong SW, Shah N, Olin R, Andreadis C, Vieaux J, Cohen E, Lopez NS, Mannis GN, Rabow M
• Where the Sidewalk Ends: Parenting as a Trainee during COVID-19.
  Cancer investigation 2023 Tsang M, Banerjee R, Quiroga D, Idossa D, Schoenbeck KL
• Refining frailty in relapsed or refractory multiple myeloma: adding the patient voice.
  The lancet. Healthy longevity 2022 Schoenbeck KL, Wildes TM

Show all (6 more) Hide

• Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers.
  Global advances in health and medicine 2021 Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P…
• Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions.
  Current hematologic malignancy reports 2021 Schoenbeck KL, Flynn KE
• Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma.
  Journal of geriatric oncology 2021 Schoenbeck KL, Fiala MA, Wildes TM
• Circumstances around falls in older adults with Cancer.
  Journal of geriatric oncology 2020 Tomczak U, Sattar S, Schoenbeck KL, Cordner T, Wildes TM
• Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide.
  Clinical interventions in aging 2020 Schoenbeck KL, Wildes TM
• Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant.
  Bone marrow transplantation 2017 Eckhert EE, Schoenbeck KL, Galligan D, McNey LM, Hwang J, Mannis GN